Contrarian Thinking, Tariff Tensions & Tesla Trouble
- NexxtGen Markets
- Apr 22
- 2 min read
Global markets are reeling as escalating trade tensions, political interference in monetary policy, and mounting recession fears unsettle investors worldwide.
📰 Top Headlines
📉 Stocks Dive, Futures Rebound
Markets reeled Monday after President Trump launched a direct attack on Fed Chair Jerome Powell, accusing him of losing control of inflation and independence. The Dow Jones dropped nearly 1,000 points, while the S&P 500 and Nasdaq 100 both shed over 2%.However, futures bounced back overnight, signalling possible stabilisation ahead of key earnings and Fed commentary.
⚡ All Eyes on Tesla
Tesla (TSLA) reports Q1 earnings today, but the EV titan has lost 44% YTD. Analysts expect profits to fall 6% YoY, with minimal revenue growth. Tesla’s deliveries missed expectations, tariffs loom large, and investor faith is being tested. Elon Musk’s political distractions aren’t helping sentiment.
"Investors want answers—not theatrics—from this earnings call," say analysts watching closely for updates on Robotaxi timelines and global expansion strategy.
🛡️ Defence Stocks & Big Pharma on Deck
Lockheed Martin (LMT), Northrop, and RTX also report today amid surging geopolitical tensions and scrutiny on defence budgets. Meanwhile, Roche is making headlines with a $50B commitment to expand operations in the U.S., a massive bet on post-tariff America that could reshape the pharma landscape.
🌍 Gold Hits $3,400 – A New All-Time High
The flight to safety continues: Gold blasted through $3,400 an ounce—its 24th record high of 2025. Year-to-date, it’s up 30%, while the VanEck Gold Miners ETF (GDX) has surged 52%. Rising tariffs, a weakening USD, and growing political unrest are fuelling the gold rush.
🔥 Contrarian Insight from Ed Yardeni
Veteran strategist Ed Yardeni is calling for calm, arguing the recent bearish hysteria may signal a market bottom. He cites historic patterns where extreme pessimism often precedes rebounds.
“Sometimes, it’s darkest before the dawn,” Yardeni said, urging investors to consider this a potential turning point.
📈 Movers & Shakers
Dyne Therapeutics (DYN) ▲ 14% – Biotech rally continues.
BioNTech (BNTX) ▲ 3% – mRNA sector rebounds.
Dunelm (DNLM.L) ▲ 13% – UK retail surprise.
Sabre Insurance (SBRE.L) ▼ 11% – Earnings miss spooks insurers.
SPDR Biotech ETF (XBI) ▼ 0.55% – Still down 28% since November.
DJ30 ▲ 0.54% – Futures recovering after Monday’s rout.
🔭 What Else to Watch
3PM GMT: Eurozone economic sentiment data. Forecast: -15.2. Could move EUR/USD.
Walgreens settles opioid case for $300M, ending legal battles after claims it ignored red flags.
U.S. Dollar Index down over 9% YTD as safe-haven currencies strengthen and Fed policy credibility is questioned.
📈 Join Us
Trade / invest in the Global Financial Markets with NexxtGen & etoro:- https://bit.ly/nexxtgenmarkets
⚠️ Risk Warning
Trading and investing carry risks. You should seek professional advice before engaging in such activities. Leverage can amplify both gains and losses. Past performance is not indicative of future results. Full risk disclosure: http://nexxtgen.pro/risk
🧾 NexxtGen Markets partner with eToro and may receive a small commission for anyone joining eToro via our website or socials.
---
Comments